1. Human Genome Sciences, Inc. (253 from 676 patents)

2. Smithkline Beecham Corporation (7 from 2,198 patents)

3. Other (5 from 831,952 patents)

4. University of Michigan (3 from 3,311 patents)

5. University of Pennsylvania (2 from 2,544 patents)

6. University of North Carolina at Chapel Hill (2 from 1,260 patents)

7. Georgetown University (2 from 478 patents)

8. Takeda Gmbh (2 from 47 patents)

9. Delta Biotechnology Limited (2 from 23 patents)

10. Applera Corporation (1 from 496 patents)

11. Mcgill University (1 from 273 patents)

12. Facet Biotech Corporation (1 from 17 patents)

13. Human Genome Sceineces, Inc. (1 from 1 patent)

14. Human Gene Sciences (1 from 1 patent)

15. Cambridge Antibody Technology Limited (28 patents)

1. 9403905 - Vascular endothelial growth factor 2

2. 9296809 - Albumin fusion proteins

3. 9221896 - Albumin fusion proteins

4. 9187548 - Antibodies that immunospecifically bind to B lymphocyte stimulator protein

5. 8993517 - Albumin fusion proteins

6. 8784809 - Vascular endothelial growth factor 2

7. 8518389 - Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides

8. 8513189 - Albumin fusion proteins

9. 8410248 - HWBAO62 polypeptides

10. 8372948 - 12 human secreted proteins

11. 8252739 - Albumin fusion proteins

12. 8216569 - Vascular endothelial growth factor 2

13. 8211439 - Albumin fusion proteins comprising insulin polypeptides

14. 8206708 - Vascular endothelial growth factor 2

15. 8143026 - Albumin fusion proteins